Sage Journals: Discover world-class research

Retricted access

Research article

First published 2001-11

Nateglinide Therapy for Type 2 Diabetes Mellitus

Terri L Levien, Danial E Baker, R Keith Campbell [...]

Annals of Pharmacotherapy

Retricted access

Other

First published 2005-03

Effect of nateglinide and glimepiride in reducing postprandial hyperglycaemia in patients with type 2 diabetes mellitus

Claudia Abletshauser, Patrick Brunel, Klaus-Henning Usadel [...]

The British Journal of Diabetes & Vascular Disease

Retricted access

Other

First published 2002-05

Comparison of the postprandial glucose and insulin profiles with nateglinide and gliclazide in type 2 diabetic patients

Anja Schweizer, Michele Ball, David R Owens [...]

The British Journal of Diabetes & Vascular Disease

Free access

Research article

First published 2009-5

Multicentre,Double-blind,Randomized Study of Mitiglinide Compared with Nateglinide in Type 2 Diabetes Mellitus Patients in China

X Gao

Journal of International Medical Research

Retricted access

Research article

First published 2015-04

Differential Therapeutic Effects of Nateglinide and Acarbose on Fasting and Postprandial Lipid Profiles: A Randomized Trial

Jian Zhou, Zixuan Deng, Jingyi Lu [...]

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2004-02

Evaluation of a New Insulinotropic Agent by Using an Innovative Technology: Efficacy and Safety of Nateglinide Determined by Continuous Glucose Monitoring

Heidemarie Abrahamian, Mario Francesconi, Anita Loiskandl [...]

Diabetes Technology & Therapeutics

Retricted access

Research article

First published 2013-06

Nateglinide and Acarbose Are Comparably Effective Reducers of Postprandial Glycemic Excursions in Chinese Antihyperglycemic Agent–Naive Subjects with Type 2 Diabetes

Jian Zhou, Hong Li, Xiuzhen Zhang [...]

Diabetes Technology & Therapeutics

Retricted access

Abstract

First published 2006-1

Is Low-Dose Continuous Nateglinide as Effective as High-Dose Three Times Daily Nateglinide in Type 2 Diabetes?

D. Gonzalez de Serna, F.M. Alba, K.E. Schwarz [...]

Journal of Investigative Medicine

Free access

Review article

First published 2018-8

Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter

Naina Mohamed Pakkir Maideen, Gobinath Manavalan, Kumar Balasubramanian

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Research article

First published 2005-1

Pharmacologic Prevention or Delay of Type 2 Diabetes Mellitus

Douglas C Anderson

Annals of Pharmacotherapy

Search results